コンテンツへスキップ
Merck
  • Peroxisome proliferator activated receptor-α/hypoxia inducible factor-1α interplay sustains carbonic anhydrase IX and apoliprotein E expression in breast cancer stem cells.

Peroxisome proliferator activated receptor-α/hypoxia inducible factor-1α interplay sustains carbonic anhydrase IX and apoliprotein E expression in breast cancer stem cells.

PloS one (2013-02-02)
Alessio Papi, Gianluca Storci, Tiziana Guarnieri, Sabrina De Carolis, Sara Bertoni, Nicola Avenia, Alessandro Sanguinetti, Angelo Sidoni, Donatella Santini, Claudio Ceccarelli, Mario Taffurelli, Marina Orlandi, Massimiliano Bonafé
要旨

Cancer stem cell biology is tightly connected to the regulation of the pro-inflammatory cytokine network. The concept of cancer stem cells "inflammatory addiction" leads to envisage the potential role of anti-inflammatory molecules as new anti-cancer targets. Here we report on the relationship between nuclear receptors activity and the modulation of the pro-inflammatory phenotype in breast cancer stem cells. Breast cancer stem cells were expanded as mammospheres from normal and tumor human breast tissues and from tumorigenic (MCF7) and non tumorigenic (MCF10) human breast cell lines. Mammospheres were exposed to the supernatant of breast tumor and normal mammary gland tissue fibroblasts. In mammospheres exposed to the breast tumor fibroblasts supernatant, autocrine tumor necrosis factor-α signalling engenders the functional interplay between peroxisome proliferator activated receptor-α and hypoxia inducible factor-1α (PPARα/HIF1α). The two proteins promote mammospheres formation and enhance each other expression via miRNA130b/miRNA17-5p-dependent mechanism which is antagonized by PPARγ. Further, the PPARα/HIF1α interplay regulates the expression of the pro-inflammatory cytokine interleukin-6, the hypoxia survival factor carbonic anhydrase IX and the plasma lipid carrier apolipoprotein E. Our data demonstrate the importance of exploring the role of nuclear receptors (PPARα/PPARγ) in the regulation of pro-inflammatory pathways, with the aim to thwart breast cancer stem cells functioning.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
炭酸脱水酵素 ウシ赤血球由来, lyophilized powder, ≥2,000 W-A units/mg protein
Sigma-Aldrich
炭酸アンヒドラーゼ ウシ赤血球由来, ≥95% (SDS-PAGE), specific activity ≥3,500 W-A units/mg protein, lyophilized powder
Sigma-Aldrich
炭酸脱水酵素 ウシ赤血球由来, BioReagent, suitable for GFC marker
Sigma-Aldrich
炭酸 アンヒドラーゼ アイソザイムII ウシ赤血球由来, lyophilized powder, ≥3,000 W-A units/mg protein
Sigma-Aldrich
炭酸脱水酵素II ヒト, recombinant, expressed in E. coli, buffered aqueous solution
Sigma-Aldrich
炭酸脱水酵素 ウシ赤血球由来, For use as a marker in SDS-PAGE
Sigma-Aldrich
炭酸 アンヒドラーゼ I ヒト赤血球由来
Sigma-Aldrich
炭酸脱水酵素II ウシ, ≥90% (SDS-PAGE), recombinant, expressed in E. coli, ≥5,000 units/mg protein, buffered aqueous solution
Sigma-Aldrich
炭酸脱水酵素アイソザイムII ヒト, ≥80%, powder, ≥3,000 W-A units/mg protein
Sigma-Aldrich
炭酸脱水酵素 ウシ赤血球由来, non-denaturing PAGE marker
Supelco
炭酸 アンヒドラーゼ I ヒト赤血球由来, Isoelectric focusing marker, pI 6.6
Sigma-Aldrich
炭酸 アンヒドラーゼ アイソザイムII ウシ赤血球由来, Isoelectric focusing marker, pI 5.4
Sigma-Aldrich
炭酸 アンヒドラーゼ アイソザイムII ウシ赤血球由来, lyophilized powder, ≥2,000 W-A units/mg protein